tm
Seeing Is Believing
tm
Seeing Is Believing
RPRX is currently covered by 2 analysts with an average price target of $52.37. This is a potential upside of $12.01 (29.76%) from yesterday's end of day stock price of $40.36.
Royalty Pharma Plc's activity chart (see below) currently has 78 price targets and 48 ratings on display. The stock rating distribution of RPRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 10.58% with an average time for these price targets to be met of 181 days.
Highest price target for RPRX is $54, Lowest price target is $42, average price target is $48.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 10-Oct-2025.
Currently out of the existing stock ratings of RPRX, 3 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 06-Apr-2022
$54
$13.83 (34.43%)
$54
3 months 3 days ago
(10-Oct-2025)
1/19 (5.26%)
$17.99 (49.96%)
197
Buy
Since 13-Jul-2020
$42
$1.83 (4.56%)
$38
5 months 22 days ago
(22-Jul-2025)
1/4 (25%)
$6.12 (17.06%)
572
Buy
Since 29-Oct-2021
$40
$-0.17 (-0.42%)
$60
1 years 2 months 19 days ago
(25-Oct-2024)
1/4 (25%)
$13.78 (52.56%)
376
Buy
Since 27-Apr-2022
$51
$10.83 (26.96%)
$50
1 years 4 months 30 days ago
(14-Aug-2024)
0/4 (0%)
$25.27 (98.21%)
Hold
Since 03-Jun-2024
$28
$-12.17 (-30.30%)
$41
1 years 7 months 10 days ago
(03-Jun-2024)
2/5 (40%)
$2.09 (8.07%)
484
What is RPRX (Royalty Pharma Plc) average time for price targets to be met?
Which analyst has the current highest performing score on RPRX (Royalty Pharma Plc) with a proven track record?
Which analyst has the current lower performing score on RPRX (Royalty Pharma Plc) with a proven track record?
Which analyst has the most public recommendations on RPRX (Royalty Pharma Plc)?
Which analyst is the currently most bullish on RPRX (Royalty Pharma Plc)?
Which analyst is the currently most reserved on RPRX (Royalty Pharma Plc)?
